Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low-birth-weight infants

American Journal of Perinatology

Volumn 30, Issue 10, 2013, Pages 849-856

  More, Kiran ^a,b   Athalye Jape, Gayatri ^a,b   Rao, Shripada ^a,c,d   Patole, Sanjay ^b,c,d  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

gastric acid; inhibitors; necrotizing enterocolitis; preterm; very low birth weight

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; DRUG SAFETY; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; NECROTIZING ENTEROCOLITIS; PHARMACODYNAMICS; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEPSIS; STOMACH ACID SECRETION; URINARY TRACT INFECTION; VERY LOW BIRTH WEIGHT;

ENTEROCOLITIS, NECROTIZING; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; RISK;

EID: 84885949157     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1333671     Document Type: Article

References (59)

1. Obladen M. Necrotizing enterocolitis-150 years of fruitless search for the cause. Neonatology: 2009; 96 203 210
2. Grave G. D., Nelson S. A., Walker W. A., et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res: 2007; 62 510 514 (Pubitemid 47476215)
3. Thompson A. M., Bizzarro M. J. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs: 2008; 68 1227 1238 (Pubitemid 351822112)
4. Henry M. C., Moss R. L. Necrotizing enterocolitis. Annu Rev Med: 2009; 60 111 124
5. Lemons J. A., Bauer C. R., Oh W., et al. NICHD Neonatal Research Network Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. Pediatrics: 2001; 107 E1
6. Guner Y. S., Chokshi N., Petrosyan M., Upperman J. S., Ford H. R., Grikscheit T. C. Necrotizing enterocolitis-bench to bedside: novel and emerging strategies. Semin Pediatr Surg: 2008; 17 255 265
7. Bisquera J. A., Cooper T. R., Berseth C. L. Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics: 2002; 109 423 428 (Pubitemid 34177504)
8. Hsueh W., Caplan M. S., Qu X. W., Tan X. D., De Plaen I. G., Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol: 2003; 6 6 23 (Pubitemid 36323623)
9. Neu J., Walker W. A. Necrotizing enterocolitis. N Engl J Med: 2011; 364 255 264
10. Stoll B. J. Epidemiology of necrotizing enterocolitis. Clin Perinatol: 1994; 21 205 218 (Pubitemid 24184709)
11. Malcolm W. F., Cotten C. M. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Clin Perinatol: 2012; 39 99 109
12. Stroup D. F., Berlin J. A., Morton S. C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA: 2000; 283 2008 2012 (Pubitemid 30214957)
13. Lin H. J., Shi L. P., Luo F., Bao Y., Ma X. L. [Value of radiographic assessment scale in necrotizing enterocolitis]. Zhongguo Dang Dai Er Ke Za Zhi: 2012; 14 97 100
14. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol: 2010; 25 603 605
15. Higgins J. PT, Deeks J. J. (editors). Chapter 7: Selecting studies and collecting data. In: Higgins J. PT, Green S. (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org
16. Sterne Jonathan A. C., Sutton A. J., Ioannidis J. P., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta analyses of randomised controlled trials. BMJ: 2011; 342 d4002
17. Terrin G., Passariello A., De Curtis M., et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics: 2012; 129 e40 e45
18. Guillet R., Stoll B. J., Cotten C. M., et al. National Institute of Child Health and Human Development Neonatal Research Network Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics: 2006; 117 e137 e142 (Pubitemid 46071566)
19. Gantz M., Roy J., Guillet R. Analyzing retrospective data with time-varying exposure: a cautionary tale of H2 blockers in ELBW neonates. Am J Perinatol: 2008; 25 93 100 (Pubitemid 351294860)
20. Ward R. M., Tammara B., Sullivan S. E., et al. Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD). Eur J Clin Pharmacol: 2010; 66 555 561
21. Omari T. I., Haslam R. R., Lundborg P., Davidson G. P. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr: 2007; 44 41 44 (Pubitemid 46071790)
22. Omari T., Lundborg P., Sandström M., et al. Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. J Pediatr: 2009; 155 222 228
23. Kierkus J., Furmaga-Jablonska W., Sullivan J. E., et al. Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease. Dig Dis Sci: 2011; 56 425 434
24. Wheatley E., Kennedy K. A. Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants. J Pediatr: 2009; 155 516 521
25. Kelly E. J., Chatfield S. L., Brownlee K. G., et al. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Arch Dis Child: 1993; 69 1 Spec No 37 39 (Pubitemid 23232979)
26. Khalaf M. N., Porat R., Brodsky N. L., Bhandari V. Clinical correlations in infants in the neonatal intensive care unit with varying severity of gastroesophageal reflux. J Pediatr Gastroenterol Nutr: 2001; 32 45 49 (Pubitemid 32094496)
27. Kuusela A. L., Ruuska T., Karikoski R., et al. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med: 1997; 25 346 351 (Pubitemid 27086074)
28. Lazzaroni M., Petrillo M., Tornaghi R., et al. Upper GI bleeding in healthy full-term infants: a case-control study. Am J Gastroenterol: 2002; 97 89 94 (Pubitemid 34059769)
29. Sarna M. S., Saili A., Dutta A. K., Sharma D. Stress associated gastric bleeding in newborn-role of ranitidine. Indian Pediatr: 1991; 28 1305 1308
30. Pulsifer-Anderson E., Guillet R. National Institutes of Health recommends the routine use of H2 blockers in preterm infants be carefully evaluated. Neonatal Netw: 2006; 25 223 224
31. Tryba M. Role of acid suppressants in intensive care medicine. Best Pract Res Clin Gastroenterol: 2001; 15 447 461 (Pubitemid 32590878)
32. Kuusela A. L., Mäki M., Ruuska T., Laippala P. Stress-induced gastric findings in critically ill newborn infants: frequency and risk factors. Intensive Care Med: 2000; 26 1501 1506
33. Mäki M., Ruuska T., Kuusela A. L., Karikoski-Leo R., Ikonen R. S. High prevalence of asymptomatic esophageal and gastric lesions in preterm infants in intensive care. Crit Care Med: 1993; 21 1863 1867 (Pubitemid 23349889)
34. Cotten C. M., Malcolm W. F. Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants. Evid Based Med: 2012; Jun 26
35. Dai D., Walker W. A. Role of bacterial colonization in neonatal necrotizing enterocolitis and its prevention. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi: 1998; 39 357 365 (Pubitemid 29113293)
36. Lichtman S. M. Bacterial translocation in humans. J Pediatr Gastroenterol Nutr: 2001; 33 1 10 (Pubitemid 32706116)
37. Ciftci I., Ozdemir M., Aktan M., Aslan K. Bacterial translocation and intestinal injury in experimental necrotizing enterocolitis model. Bratisl Lek Listy: 2012; 113 206 210
38. Giannella R. A., Broitman S. A., Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut: 1972; 13 251 256
39. Kelly E. J., Chatfield S. L., Brownlee K. G., et al. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Arch Dis Child: 1993; 69 1 Spec No 37 39 (Pubitemid 23232979)
40. Carrion V., Egan E. A. Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr: 1990; 11 317 323 (Pubitemid 20308956)
41. Başaran U. N., Celayir S., Eray N., Oztürk R., Senyüz O. F. The effect of an H2-receptor antagonist on small-bowel colonization and bacterial translocation in newborn rats. Pediatr Surg Int: 1998; 13 118 120 (Pubitemid 28143045)
42. Karikoski R., Ruuska T. [Stress-related gastric mucosal lesions in neonatal intensive care patients-an unrecognized problem]. Duodecim: 1998; 114 313, 315-316
43. Cothran D. S., Borowitz S. M., Sutphen J. L., Dudley S. M., Donowitz L. G. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol: 1997; 17 383 388 (Pubitemid 127454932)
44. Beck-Sague C. M., Azimi P., Fonseca S. N., et al. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J: 1994; 13 1110 1116 (Pubitemid 24376768)
45. Kelly E. J., Newell S. J., Brownlee K. G., Primrose J. N., Dear P. R. Gastric acid secretion in preterm infants. Early Hum Dev: 1993; 35 215 220 (Pubitemid 24053222)
46. Choung R. S., Ruff K. C., Malhotra A., et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther: 2011; 33 1059 1067
47. Lewis S. J., Franco S., Young G., O'Keefe S. J. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther: 1996; 10 557 561 (Pubitemid 26254799)
48. Wang K., Lin H. J., Perng C. L., et al. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach. Hepatogastroenterology: 2004; 51 1540 1543 (Pubitemid 38987525)
49. Sanaka M., Yamamoto T., Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review. Dig Dis Sci: 2010; 55 2431 2440
50. Parkman H. P., Urbain J. L., Knight L. C., et al. Effect of gastric acid suppressants on human gastric motility. Gut: 1998; 42 243 250 (Pubitemid 28212180)
51. Goddard A. F., Spiller R. C. The effect of omeprazole on gastric juice viscosity, pH and bacterial counts. Aliment Pharmacol Ther: 1996; 10 105 109 (Pubitemid 26070006)
52. Miano T. A., Reichert M. G., Houle T. T., MacGregor D. A., Kincaid E. H., Bowton D. L. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. Chest: 2009; 136 440 447
53. Wandall J. H. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut: 1992; 33 617 621
54. Agastya G., West B. C., Callahan J. M. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol: 2000; 22 357 372 (Pubitemid 30646117)
55. Yoshida N., Yoshikawa T., Tanaka Y., et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther: 2000; 14 01 74 81 (Pubitemid 30199109)
56. Biçakçi U., Tander B., Aritürk E., et al. Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int: 2005; 21 800 805 (Pubitemid 41504118)
57. Cadir F. O., Bicakci U., Tander B., et al. Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int: 2008; 24 809 813
58. Shivanna B., Jiang W., Wang L., Couroucli X. I., Moorthy B. Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes. J Pharmacol Exp Ther: 2011; 339 106 114
59. Shivanna B., Chu C., Welty S. E., et al. Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor. Free Radic Biol Med: 2011; 51 1910 1917